Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation
Current Opinion in Cardiology, 06/26/2012
Liew A et al. – The new oral anticoagulants (OACs) represent a major advance for patients with atrial fibrillation with the potential to reduce morbidity and mortality due to cardioembolic stroke.



